News

August 7, 2008 - St. Jude Medical Inc. today said it received regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the...

July 8, 2008 - Foothills Medical Centre, a leading medical centre for treating patients with cardiac rhythm abnormalities in Calgary, Alberta, has become the first facility in Canada to use the...

July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-...

March 11, 2008 - Sorin Group's ELA Medical received the FDA’s approval to market ISOLINE, a new defibrillation lead designed with redundant insulation and abrasion resistant materials for...

March 3, 2008 - Boston Scientific Corp. received CE Mark approval of its ACUITY Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac...

October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for...

October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance...

September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the...

May 11, 2007 — St. Jude Medical Inc. has announced FDA approval of its new OptiSense lead, a first-of-its-kind "smart" pacing lead designed to offer more accurate sensing in the upper chamber of...